Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

The Joint Department of Biomedical Engineering, a collaboration between NC State and UNC-CH, received a $20 million ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...

A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Moderna shares fell 3% in premarket trading after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

MARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group ...